Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Ipca-Labs"

4 News Found

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases
News | June 12, 2026

Ipca Labs, BRL to co-develop next-gen biologics for cancer and autoimmune diseases

The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr
News | August 05, 2021

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr

Total income grew in the quarter

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer
News | November 24, 2021

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer

For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore

Domestic growth to the fore as US weakness persists: ICICI Direct
News | October 19, 2021

Domestic growth to the fore as US weakness persists: ICICI Direct

ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM

Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel

Major UK study to evaluate newborn screening for spinal muscular atrophy

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Dr. Ramesh Hariharan Chief Executive Officer, Strand Life Sciences

Packaging